Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge

被引:7
|
作者
Powell, Thomas J. [1 ]
Jacobs, Andrea [1 ]
Tang, Jie [1 ]
Cardenas, Edwin [1 ]
Palath, Naveen [1 ,3 ]
Daniels, Jennifer [1 ,4 ]
Boyd, James G. [1 ]
Bergeron, Harrison C. [2 ]
Jorquera, Patricia A. [2 ,5 ]
Tripp, Ralph A. [2 ]
机构
[1] Artificial Cell Technol, 5 Sci Pk,Suite 13, New Haven, CT 06511 USA
[2] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA
[3] Pfizer Inc, Andover, MA 01810 USA
[4] August Bioserv, Nashville, TN 37210 USA
[5] Moderna, Cambridge, MA 02139 USA
关键词
RSV; G protein; vaccine; microparticle; CX3C; eosinophils; RESPIRATORY-SYNCYTIAL-VIRUS; GLYCOPROTEIN MONOCLONAL-ANTIBODY; MESSENGER-RNA EXPRESSION; T-CELLS PROTECT; FUSION GLYCOPROTEIN; F PROTEIN; PHAGOSOME MATURATION; RECEPTOR STIMULATION; ENHANCED DISEASE; BALB/C MICE;
D O I
10.3390/vaccines10122078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Layer-by-layer microparticle (LbL-MP) fabrication was used to produce synthetic vaccines presenting a fusion peptide containing RSV G protein CX3C chemokine motif and a CD8 epitope of the RSV matrix protein 2 (GM2) with or without a covalently linked TLR2 agonist (Pam3.GM2). Immunization of BALB/c mice with either GM2 or Pam3.GM2 LbL-MP in the absence of adjuvant elicited G-specific antibody responses and M2-specific CD8+ T-cell responses. Following challenge with RSV, mice immunized with the GM2 LbL-MP vaccine developed a Th2-biased immune response in the lungs with elevated levels of IL-4, IL-5, IL-13, and eotaxin in the bronchoalveolar lavage (BAL) fluid and a pulmonary influx of eosinophils. By comparison, mice immunized with the Pam3.GM2 LbL-MP vaccine had considerably lower to non-detectable levels of the Th2 cytokines and chemokines and very low numbers of eosinophils in the BAL fluid post-RSV challenge. In addition, mice immunized with the Pam3.GM2 LbL-MP also had higher levels of RSV G-specific IgG2a and IgG2b in the post-challenge BAL fluid compared to those immunized with the GM2 LbL-MP vaccine. While both candidates protected mice from infection following challenge, as evidenced by the reduction or elimination of RSV plaques, the inclusion of the TLR2 agonist yielded a more potent antibody response, greater protection, and a clear shift away from Th2/eosinophil responses. Since the failure of formalin-inactivated RSV (FI-RSV) vaccines tested in the 1960s has been hypothesized to be partly due to the ablation of host TLR engagement by the vaccine and inappropriate Th2 responses upon subsequent viral infection, these findings stress the importance of appropriate engagement of the innate immune response during initial exposure to RSV G CX3C.
引用
收藏
页数:17
相关论文
共 2 条
  • [1] Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease
    Jorquera, Patricia A.
    Choi, Youngjoo
    Oakley, Katie E.
    Powell, Thomas J.
    Boyd, James G.
    Palath, Naveen
    Haynes, Lia M.
    Anderson, Larry J.
    Tripp, Ralph A.
    PLOS ONE, 2013, 8 (09):
  • [2] Nanoparticle vaccines comprising the respiratory syncytial virus G Protein CX3C chemokine motif induce robust immunity protecting from challenge and disease
    Tripp, Ralph
    Choi, Youngjoo
    Powell, Thomas
    Boyd, James
    Palath, Naveen
    Haynes, Lia
    Anderson, Larry
    Jorquera, Patricia
    JOURNAL OF IMMUNOLOGY, 2013, 190